DK139029C - - Google Patents
Info
- Publication number
- DK139029C DK139029C DK318177A DK318177A DK139029C DK 139029 C DK139029 C DK 139029C DK 318177 A DK318177 A DK 318177A DK 318177 A DK318177 A DK 318177A DK 139029 C DK139029 C DK 139029C
- Authority
- DK
- Denmark
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/706,123 US4080454A (en) | 1976-07-16 | 1976-07-16 | 5-M-Tolyloxyuracil, anti-ulcer agent |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK318177A DK318177A (pt) | 1978-01-17 |
| DK139029B DK139029B (da) | 1978-12-04 |
| DK139029C true DK139029C (pt) | 1979-05-07 |
Family
ID=24836300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK318177AA DK139029B (da) | 1976-07-16 | 1977-07-13 | Analogifremgangsmåde til fremstilling af 5-m-tolyloxyuracil. |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US4080454A (pt) |
| JP (1) | JPS5337673A (pt) |
| AR (1) | AR213652A1 (pt) |
| AT (1) | AT351561B (pt) |
| BE (1) | BE856710A (pt) |
| CA (1) | CA1061788A (pt) |
| CH (1) | CH622512A5 (pt) |
| CS (1) | CS212264B2 (pt) |
| DD (1) | DD131556A5 (pt) |
| DE (1) | DE2731736A1 (pt) |
| DK (1) | DK139029B (pt) |
| EG (1) | EG12762A (pt) |
| ES (1) | ES460686A1 (pt) |
| FI (1) | FI772183A (pt) |
| FR (1) | FR2358399A1 (pt) |
| GB (1) | GB1542178A (pt) |
| GR (1) | GR68686B (pt) |
| HU (1) | HU177713B (pt) |
| IL (1) | IL52409A (pt) |
| LU (1) | LU77764A1 (pt) |
| NL (1) | NL7707729A (pt) |
| NO (1) | NO772489L (pt) |
| PH (1) | PH13190A (pt) |
| PL (1) | PL103783B1 (pt) |
| PT (1) | PT66808B (pt) |
| SE (1) | SE421125B (pt) |
| SU (1) | SU673169A3 (pt) |
| YU (1) | YU171677A (pt) |
| ZA (1) | ZA773927B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55158095A (en) * | 1979-05-25 | 1980-12-09 | Zenkosha Tokei Kk | Controller for washing machine |
| JPS5822406U (ja) * | 1981-08-04 | 1983-02-12 | トキコ株式会社 | 消音器 |
| US7776870B2 (en) | 2005-08-22 | 2010-08-17 | Melior Pharmaceuticals I, Inc. | Methods for modulating Lyn kinase activity and treating related disorders |
| CA2678813A1 (en) * | 2007-02-20 | 2008-08-28 | Melior Pharmaceuticals I, Inc. | Methods of identifying activators of lyn kinase |
| CA2693809A1 (en) * | 2007-07-23 | 2009-01-29 | Melior Discovery, Inc. | Methods of activating irs-1 and akt |
| US8552184B2 (en) * | 2008-07-03 | 2013-10-08 | Melior Pharmaceuticals I, Inc. | Compounds and methods for treating disorders related to glucose metabolism |
| WO2011150300A1 (en) * | 2010-05-28 | 2011-12-01 | Melior Pharmaceuticals I, Inc. | Prevention of pancreatic beta cell degeneration |
| BR112019021140A2 (pt) | 2017-04-10 | 2020-05-19 | Univ Louisiana State | composição, método para reduzir os níveis de glicose no sangue, ganho de peso ou níveis de depósito de gordura, ou tratamento, método de indução do bege de adipócitos ou prevenção da degeneração das células beta do pâncreas, e, ativador de lyn cinase e agonista de trpm8 para uso na redução dos níveis de glicose no sangue, ganho de peso ou níveis de depósito de gordura, ou tratamento. |
| WO2019164799A1 (en) | 2018-02-21 | 2019-08-29 | Melior Pharmaceuticals I, Inc. | Treatment of liver diseases |
-
1976
- 1976-07-16 US US05/706,123 patent/US4080454A/en not_active Expired - Lifetime
-
1977
- 1977-06-27 GR GR53819A patent/GR68686B/el unknown
- 1977-06-27 CA CA281,423A patent/CA1061788A/en not_active Expired
- 1977-06-28 IL IL52409A patent/IL52409A/xx unknown
- 1977-06-28 SE SE7707471A patent/SE421125B/xx unknown
- 1977-06-29 ZA ZA00773927A patent/ZA773927B/xx unknown
- 1977-07-05 PH PH19953A patent/PH13190A/en unknown
- 1977-07-11 FR FR7721285A patent/FR2358399A1/fr active Granted
- 1977-07-11 BE BE1008274A patent/BE856710A/xx unknown
- 1977-07-11 DE DE19772731736 patent/DE2731736A1/de not_active Withdrawn
- 1977-07-11 YU YU01716/77A patent/YU171677A/xx unknown
- 1977-07-12 NL NL7707729A patent/NL7707729A/xx not_active Application Discontinuation
- 1977-07-12 JP JP8349077A patent/JPS5337673A/ja active Granted
- 1977-07-13 SU SU772502606A patent/SU673169A3/ru active
- 1977-07-13 EG EG418/77A patent/EG12762A/xx active
- 1977-07-13 NO NO772489A patent/NO772489L/no unknown
- 1977-07-13 CH CH870277A patent/CH622512A5/fr not_active IP Right Cessation
- 1977-07-13 ES ES460686A patent/ES460686A1/es not_active Expired
- 1977-07-13 DK DK318177AA patent/DK139029B/da unknown
- 1977-07-13 FI FI772183A patent/FI772183A/fi not_active Application Discontinuation
- 1977-07-13 HU HU77PI583A patent/HU177713B/hu unknown
- 1977-07-13 CS CS774680A patent/CS212264B2/cs unknown
- 1977-07-14 GB GB7729667A patent/GB1542178A/en not_active Expired
- 1977-07-14 AR AR268432A patent/AR213652A1/es active
- 1977-07-14 PL PL1977199633A patent/PL103783B1/pl unknown
- 1977-07-14 LU LU77764A patent/LU77764A1/xx unknown
- 1977-07-14 DD DD7700200058A patent/DD131556A5/xx unknown
- 1977-07-14 PT PT66808A patent/PT66808B/pt unknown
- 1977-07-14 AT AT509277A patent/AT351561B/de not_active IP Right Cessation